Sep 17, 2015 - Dean Foods (DF) announced Ralph Scozzafava as its new Chief Operating Officer
Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
Sep 15, 2015 - AbbVie (ABBV) is looking to get Imbruvica approved in the U.S. for the front-line treatment of patients suffering from chronic lymphocytic leukemia.
Sep 15, 2015 - Given heightened volatility and uncertainty, investors should invest in high-quality stocks through a basket form.
Sep 11, 2015 - Gilead Sciences, Inc. (GILD) announced successful pricing of its senior note offering worth $10 billion in aggregate principal amount.
Sep 10, 2015 - Johnson & Johnson (NYSE:JNJ) 2015 Wells Fargo 10th Annual Healthcare Conference Call September 10, 2015, 12:25 PM ET Executives Alex Gorsky - Chairman of the Board of Directors and Chief Executive
Sep 09, 2015 - Tetraphase Pharmaceuticals (TTPH) announced that the IGNITE2 study on eravacycline for complicated urinary tract infections did not meet its primary endpoint.
Sep 03, 2015 - Gilead Sciences Inc. (GILD) announced positive data from a phase III study on fixed-dose combinations of Emtriva and tenofoviralafenamide for the treatment of HIV-1 infection.
Sep 03, 2015 - Lannett Company (LCI) inked a deal with UCB to buy its U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals Inc.
Sep 01, 2015 - Benchmarks ended in the red on Monday after Federal Vice Chairman Stanley Fischer’s comments on Saturday left possibilities of September rate hike wide open